Show items per page
Elements: 6
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
DNMT3A mutation is associated with increased age and adverse outcome in adult T-cell acute lymphoblastic leukemia Bond, Jonathan; Touzart, Aurore; Leprêtre, Stéphane; Graux, Carlos; ... Boissel, Nicolas 2019
add to browser selection
PAX5 P80R mutation identifies a novel subtype of B-cell precursor acute lymphoblastic leukemia with favorable outcome Passet, Marie; Boissel, Nicolas; Sigaux, François; Saillard, Colombe; ... Clappier, Emmanuelle 2019
add to browser selection
Intensified Therapy of Acute Lymphoblastic Leukemia in Adults: Report of the Randomized GRAALL-2005 Clinical Trial Huguet, Françoise; Chevret, Sylvie; Leguay, Thibaut; Thomas, Xavier; ... Dombret, Hervé 2018
add to browser selection
Rituximab in B-Lineage Adult Acute Lymphoblastic Leukemia Maury, Sébastien; Chevret, Sylvie; Thomas, Xavier; Heim, Dominik; ... Dombret, Hervé 2016
add to browser selection
Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia Beldjord, Kheira; Chevret, Sylvie; Asnafi, Vahid; Huguet, Françoise; ... Dombret, Hervé 2014
add to browser selection
Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/FBXW7 mutations, but not of low ERG/BAALC expression: a GRAALL study Ben Abdelali, Raouf; Asnafi, Vahid; Leguay, Thibaut; Boissel, Nicolas; ... Ifrah, Norbert 2011